GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » FOXO Technologies Inc (AMEX:FOXO) » Definitions » Momentum Rank

FOXO Technologies (FOXO Technologies) Momentum Rank : 0 (As of Jun. 10, 2024)


View and export this data going back to 2022. Start your Free Trial

What is FOXO Technologies Momentum Rank?

FOXO Technologies has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


FOXO Technologies Momentum Rank Related Terms

Thank you for viewing the detailed overview of FOXO Technologies's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


FOXO Technologies (FOXO Technologies) Business Description

Traded in Other Exchanges
N/A
Address
729 Washington Avenue N, Suite 600, Minneapolis, MN, USA, 55401
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging.
Executives
Martin Christopher Ward officer: Interim CFO CHALKSTREAM, KINGS SOMBORNE, STOCKBRIDGE X0 S020 6NZ
Mark Brian White director, officer: Interim CEO IMMEUBLE MILA, CHAMPERY V8 1874
Dowling Vincent J. Jr 10 percent owner 54 LEDYARD, WEST HARTFORD CT 06117
Gwg Holdings, Inc. 10 percent owner 325 N. ST. PAUL STREET, SUITE 2650, DALLAS TX 75201
Taylor Fay officer: Chief Operating Officer 729 N. WASHINGTON AVE, SUITE 600, MINNEAPOLIS MN 55401
Jon Sabes director, 10 percent owner, officer: CEO, Chairman 701 NORTH THIRD STREET, MINNEAPOLIS MN 55401
Bret Barnes director 220 SOUTH SIXTH STREET, MINNEAPOLIS MN 55402
Brian Chen officer: Chief Science Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Erin Sharoni officer: Chief Product Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Michael Will officer: General Counsel 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Tyler Danielson officer: Chief Technology Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Murdoc Khaleghi director 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Robert Potashnick officer: Chief Financial Officer 220 SOUTH SIXTH STREET, SUITE 1200, MINNEAPOLIS MN 55402
Plc Barclays 10 percent owner 1 CHURCHILL PLACE, CANARY WHARF, LONDON X0 E14 5HP
Paul Britton Newhouse director ONE CITY CENTRE, 1021 MAIN STREET SUITE 1960, HOUSTON TX 77002

FOXO Technologies (FOXO Technologies) Headlines